Evidence map›Paper›PMID 35286453›Full record

ArticlePediatric nephrology (Berlin, Germany)2022

Relationship between biomarkers of tubular injury and intrarenal hemodynamic dysfunction in youth with type 1 diabetes.

Melissa J Johnson, Kalie L Tommerdahl, Carissa Vinovskis, Sushrut Waikar, Trenton Reinicke, Chirag R Parikh, Wassim Obeid, Robert G Nelson, Daniel H van Raalte, Laura Pyle and 2 more

Open access · greenAbstract read
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Melissa J JohnsonDepartment of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kalie L TommerdahlDepartment of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Carissa VinovskisDepartment of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Sushrut WaikarSection of Nephrology, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
Trenton ReinickeDepartment of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Chirag R ParikhDivision of Nephrology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Wassim ObeidDivision of Nephrology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Robert G NelsonChronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.
Daniel H van RaalteDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUMC, Amsterdam, The Netherlands.
Laura PyleDepartment of Biostatistics, Colorado School of Public Health, Aurora, CO, USA.
Kristen J NadeauDepartment of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Petter BjornstadDepartment of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Petter.Bjornstad@childrenscolorado.org.
Children's Hospital Colorado · USJohns Hopkins University · USUniversity of Colorado Anschutz Medical Campus · USAmsterdam University Medical Centers · NLBoston Medical Center · USColorado School of Public Health · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
Epidemiology, Pathophysiology and Treatment of Diabetic NephropathyZIADK069062 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI NELSON, ROBERT G · 2009 to 2023
$10.1M
Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft OutcomesR01DK093770 · NIDDK · YALE UNIVERSITY · PI Chirag R Parikh · 2012 to 2026
$9.5M
Unraveling the Impact of Per- and Polyfluoroalkyl Substances on Early Kidney Injury in Adolescents with Obesity and DiabetesR01DK129211 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Petter Bjornstad · 2021 to 2026
$3.9M
Leveraging Clinical Trials of Diabetic Kidney Disease to Advance BiomarkersU01DK106962 · NIDDK · YALE UNIVERSITY · PI COCA, STEVEN G, PARIKH, CHIRAG R · 2015 to 2019
$1.3M
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyK23DK116720 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER · 2018 to 2022
$963k
MANATEE-T1D: Metformin ANd AutomaTEd insulin delivery system Effects on renal vascular resistance, insulin sensitivity, and cardiometabolic function in youth with Type 1 DiabetesK23HL159292 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI TOMMERDAHL, KALIE L · 2021 to 2025
$931k
AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)UH3DK114866 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PARIKH, CHIRAG R · 2019 to 2021
$900k
Measuring metabolically active kidney tissue in autosomal dominant polycystic kidney diseaseR21DK129720 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER, GITOMER, BERENICE YOLANDE · 2021 to 2021
$242k
NHLBI NIH HHS K23 HL159292NHLBI NIH HHS L40 HL159798NHLBI NIH HHS R01 HL085757NIDDK NIH HHS K23 DK116720NIDDK NIH HHS P30 DK116073NIDDK NIH HHS R01 DK093770NIDDK NIH HHS R01 DK129211NIDDK NIH HHS R21 DK129720NIDDK NIH HHS U01 DK106962NIDDK NIH HHS U24 DK114886NIDDK NIH HHS UH3 DK114866
6 · The paper itself

Abstract

backgroundEarly identification of youth with type 1 diabetes (T1D) at risk for diabetic kidney disease may improve clinical outcomes. We examined the cross-sectional relationship between kidney biomarkers neutrophil gelatinase-associated lipocalin (NGAL), copeptin, interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1), chitinase-3-like protein-1 (YKL-40), and monocyte chemoattractant protein-1 (MCP-1) and intrarenal hemodynamic function in adolescents with T1D.

methodsUrine albumin-to-creatinine ratio (UACR), renal vascular resistance (RVR), glomerular filtration rate (GFR), intraglomerular pressure (P

resultsFifty adolescents with T1D (16.1 ± 3.0 years, HbA1c 8.6 ± 1.2%) and 20 adolescents of comparable BMI without T1D (16.1 ± 2.9 years, HbA1c 5.2 ± 0.2%) were enrolled. Adolescents with T1D demonstrated significantly higher GFR, RPF, R

conclusionsHigher concentrations of biomarkers YKL-40 and KIM-1 may help define the risk for intraglomerular hemodynamic dysfunction in youth with T1D. A higher resolution version of the Graphical abstract is available as Supplementary information.

Indexed as

Diabetes Mellitus, Type 1AdolescentAlbuminsBiomarkersChemokine CCL2Chitinase-3-Like Protein 1CreatinineGlycated HemoglobinHemodynamicsHumansInterleukin-18Lipocalin-2AlbuminsBiomarkersChemokine CCL2Chitinase-3-Like Protein 1CreatinineGlycated HemoglobinInterleukin-18Lipocalin-2BiomarkersDiabetic kidney diseaseKIM-1PediatricsTubular injuryYKL-40

Identifiers

PMID35286453
PMCPMC9470783
OpenAlexW4221088319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.